Cardinal Health (CAH) 81.79 $CAH Cardinal Health Set to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardinal Health (CAH) 81.79 $CAH

Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 2.51%
Comtex SmarTrend(R) - Wed Jul 06, 1:25PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)

Watch for Cardinal Health to Potentially Pullback After Gaining 2.51% Yesterday
Comtex SmarTrend(R) - Wed Jul 06, 1:24PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.77 to a high of $80.19. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $78.69 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)

Akers Biosciences Chlamydia Rapid Test Results Positive
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 8:33AM CDT
Shares of Akers Biosciences Inc. (AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid test.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)

Cardinal Health Appoints Pamela O. Kimmet Chief Human Resources Officer
PR Newswire - Thu Jun 30, 3:15PM CDT
Cardinal Health, a global healthcare services and products company, today announced the appointment of Pamela O. Kimmet as Chief Human Resources Officer, effective today. Pam joins the company from Coca-Cola Enterprises, where she was senior vice president, Human Resources. She will report to George S. Barrett, chairman and CEO of Cardinal Health.
CAH: 81.79 (+0.73)

Look for Shares of Cardinal Health to Potentially Pullback after Yesterday's 2.36% Rise
Comtex SmarTrend(R) - Wed Jun 29, 4:11PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $75.69 to a high of $77.21. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $76.25 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)

Akers Biosciences Signs Distribution Agreement, Shares Rally
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 6:49AM CDT
Akers Biosciences Inc. (AKER) recently signed an agreement with Aero-Med, a division of Cardinal Health (CAH), to distribute its disposable breathalyzer.
BSX: 23.75 (-0.02), ICUI: 114.77 (-0.97), CAH: 81.79 (+0.73), AKER: 2.76 (-0.04)

SmarTrend Watching for Potential Rebound in Shares of Cardinal Health After 1.37% Loss
Comtex SmarTrend(R) - Wed Jun 15, 11:58AM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $76.67 to a high of $78.08. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $77.57 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)

Cardinal Health to Prepare NETSPOT(TM) Doses for Advanced Accelerator Applications
GlobeNewswire - Thu Jun 09, 6:51AM CDT
Advanced Accelerator Applications S.A. (NASDAQ:AAAP) ("AAA" or "the Company", an international specialist in Molecular Nuclear Medicine (MNM), today announced that it has selected Cardinal Health, Inc. (NYSE:CAH), a healthcare services company operating the largest radiopharmaceutical network in the United States, to supply gallium 68 (Ga 68) dotatate doses prepared with a novel kit to U.S. hospitals and imaging centers.
CAH: 81.79 (+0.73), AAAP: 30.88 (-0.10)

Sterigenics International Names Michael B. Petras, Jr. as Chief Executive Officer
PR Newswire - Wed Jun 01, 12:00PM CDT
Sterigenics International LLC ("Sterigenics" or "the Company", the leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, today announced that Michael B. Petras, Jr. has been appointed Chief Executive Officer ("CEO", effective June 20, 2016. Mr. Petras succeeds Michael Mulhern, who has been appointed to serve as Executive Chairman of the Sterigenics Board of Directors.
CAH: 81.79 (+0.73)

SmarTrend Watching for Potential Pullback in Shares of Cardinal Health After 1.26% Gain
Comtex SmarTrend(R) - Fri May 27, 12:33PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)

Cardinal Health Set to Possibly Pullback After Yesterday's Rally of 1.26%
Comtex SmarTrend(R) - Fri May 27, 12:31PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $77.45 to a high of $78.36. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $77.99 on volume of 668,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAH: 81.79 (+0.73)

Fort McMurray Fire Victims to Receive Aid from Cardinal Health
CNW Group - Tue May 17, 8:00AM CDT
Company donates more than $85,000 in cash and health care products
CAH: 81.79 (+0.73)

Cordis Announces Return to the Drug-Eluting Stent Market
PR Newswire - Thu May 12, 8:00AM CDT
Cardinal Health today announced that it has entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health's interventional vascular business, to sell Biosensors' coronary stent portfolio. Cordis will sell Biosensors' coronary stents in select countries in Europe, the Middle East, Africa, Australia and New Zealand. This marks Cordis' return to the drug-eluting stent (DES) market and the beginning of a long-term partnership between Cardinal Health and Biosensors to further leverage their respective distribution capabilities in select regions.
CAH: 81.79 (+0.73)

Moving Average Crossover Alert: Cardinal Health (CAH)
Zacks Equity Research - Zacks Investment Research - Mon May 09, 9:12AM CDT
Cardinal Health, Inc. (CAH) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
CAH: 81.79 (+0.73)

/C O R R E C T I O N -- Cardinal Health/
PR Newswire - Wed May 04, 4:40PM CDT
In the news release, Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program, issued 04-May-2016 by Cardinal Health over PR Newswire, we are advised by the company that the first paragraph, second sentence, should read, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2016." rather than, "The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015." as originally issued inadvertently. The complete, corrected release follows:
CAH: 81.79 (+0.73)

Cardinal Health Board of Directors Approves Quarterly Dividend, Authorizes Share Repurchase Program
PR Newswire - Wed May 04, 3:08PM CDT
Cardinal Health today announced that its board of directors approved a 16 percent increase in the company's quarterly dividend to $0.4489 per share, or $1.80 per share on an annualized basis. The quarterly dividend is payable on July 15, 2016, to shareholders of record at the close of business on July 1, 2015.
CAH: 81.79 (+0.73)

Watch for Cardinal Health to Potentially Rebound After Falling 6.94% Yesterday
Comtex SmarTrend(R) - Thu Apr 28, 12:14PM CDT
Cardinal Health (NYSE:CAH) traded in a range yesterday that spanned from a low of $79.36 to a high of $83.91. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $85.72 on volume of 3.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CAH: 81.79 (+0.73)

Cardinal Health (CAH) Tops Q3 Earnings, FY16 View Revised
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:23AM CDT
Cardinal Health (CAH) reported third-quarter fiscal 2016 adjusted earnings of $1.43 per share, which beat the Zacks Consensus Estimate by a dime.
ALGN: 84.37 (+1.00), CAH: 81.79 (+0.73), CVS: 96.06 (-0.78), HSIC: 181.77 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 209

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 258

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 195

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 150

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 118

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 215

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 112

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Future of Hydrogen Detection Technology and Growth

Updated Category News Views 545

Hydrogen Detection Market Size & Growth Insights The hydrogen detection market is on a remarkable trajectory, aiming to reach an impressive USD 642.39 million by 2032. This growth represents a substantial compound annual growth rate (CAGR) of 11.89% from 2024 to 2032, starting with a market valuation of USD 234.9 million in 2023. The ongoing emphasis on hydrogen as a...

Continue Reading
Insights into Novonesis’ Share Buyback Program Transactions

Updated Category News Views 336

Understanding Novonesis’ Share Buyback Program The financial landscape continuously evolves, and one significant strategy that companies often utilize is a share buyback program. Novonesis is currently engaging in such a strategy, which has piqued the interest of many investors and market analysts alike. This program allows a company to repurchase its shares from the...

Continue Reading
Discover Chippewa Boots' Newest October Selection for Workers

Updated Category News Views 250

October Boot of the Month: The Paladin and Tinsley Chippewa Boots proudly presents its October Boot of the Month: the Paladin and Tinsley, both exceptional 8-inch Waterproof Insulated Steel Toe Loggers. These boots are designed to excel in tough work environments while providing the necessary protection, comfort, and performance that professionals need. Features of the...

Continue Reading
Understanding Broadcom's Recent Options Activity and Insights

Updated Category News Views 100

Broadcom's Options Activity: What Investors Are Observing Investors with considerable capital are showing a notable interest in Broadcom (NASDAQ: AVGO), currently adopting a more cautious stance than usual. This trend is captured through significant options activity that market players should closely monitor. While the identities of these investors remain undisclosed, the...

Continue Reading
Santa Clara University Celebrates Diverse Class of 2028

Updated Category News Views 597

Welcoming a New Era at Santa Clara University Santa Clara University has kicked off a new chapter with over 1,800 enthusiastic undergraduates joining the ranks during a lively Welcome Weekend. This event was not just about filling seats; it was a whirlwind of social gatherings—from dance parties to heartfelt ceremonies—showing SCU’s determination to cultivate an...

Continue Reading